CMA welcomes B3-skin cancer findings

keytruda - melanoma
CEO of Complementary Medicines Australia Carl Gibson has welcomed results from a University of Sydney study, published in the New England Journal of Medicine, which show that vitamin B3 (nicotinamide) can cut the risk of new skin cancers by 23%. In this double-blind, randomised, controlled trial, participants who had, in the last five years, had

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Breast cancer 5-year survival rates improving in young women
Next PHAA welcomes Implementation Plan for Aboriginal and Torres Strait Islander health